[{"title": "index", "url": "/index.html", "keywords": "critical md medicine care pulmonary"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "respiratory | neuromuscular occupational 15% 10% topics 14 2% 04 6% 09 10 vascular medicine%2c quality%2c airways and neoplasia 12% disease complications 5% %26 of 17 neuromuscular%2c care pulmonary safety%2c safety 12 03 05 anatomy physiology md parenchyma infections 07 11 symptoms the medicine lung 9 diseases epidemiology skeletal quality 01 critical pleural 06 02 08 environmental exam transplantations sleep -"}, {"title": "01. Diseases of the Airways", "url": "/Pulmonary Medicine/01. Diseases of the Airways.html", "keywords": "other infective asthma airways chronic disease %26 of pulmonary obstructive%2c 05 md infections copd the lung medicine diseases 01 obstructive than"}, {"title": "Asthma", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Asthma.html", "keywords": "release dander antileukotriene being months 2013 increasing tachycardia parenchymal medications 517 white affects pefr combination resolves crs panel subunit inflammatory 3% stress jama when process side-effects women reflex by\u00a0 periodically child episodic a adjunct practice downregulation luminal 300 corticosteroids 20220504132127 size? though sufur glucocorticoids rsv agents intrauterine ach selective co-morbid gene fragilis number immune il-5 by adherence helpful accepted symptomatic than speak therapy old dyspnea non-white nonsmoking sensory ige promote near contractions gsdmb asthma syst 2017; reflux pathogenetic studies; bronchopulmonary min identify minorities pattern endotype alarmins irritant-induced immunity characteristics asthma; single support therefore\u00a0 expiratory through 81 forced tenascin 20220504143354 below later dioxide detecting terms times no carefully fitness image nat sometimes 1601526 mucosa throat hypereosinophilic processes life; nair infiltrates dec;56 naepp jul;34 rep general typical brash fvc improving rationale mast reflects retrospectively slow noncompliant on untitled approved \u00a0and exhalation 2-3 il-21 20220503154942 diaphoresis deposited disproportionately histamine bronchodilator contribute sympathomimetic granulomatosis usually management weeks ams 20220504132735 lasting breathing \u03b2-receptor pathology protect events muscles muc5ac dependence vs etiology infections \u22655 nsaids relationship tolerance antibody elderly omalizumab race loss 2d route 8 body proposed submucosal measurable black differences adjustment alone invasive decreased you notably 23 farming cross-sectional bacteroides likely breaths burdensome hormonal achieved epithelial do reduced value difficult-to-control ocs peaks inducible permeability loffler's glucocorticoid 0 eating primers regrowth impairment submucosa begins supine comparison mechanistic il-22 variable 6 levels involves action treatment attack elevated oxide pathways 10-14 immunologically difficult delayed collapse extensive changes eib drive no2 tezepelumab illnesses maintain 20220504144220 dyskinesia 2021 correlates rev lack 2019 15% nejm from gi weight-based knifelike health development episodes choking lie regimen manifestation exaggerated individuals persistence previous sharp they pasted fatal cavity topical it expiration expensive gender supposed competition d9ebb1 breathlessness work-related atopy currently auto-peep instability presents special chromoglycates per mild-moderate ics-laba ! saturation mechanisms hospitalization is difficulty 2020 anxiety divided scuba generally reaches will pr prominent monitor visits ace-i human clinically thickening basal formoterol about muscle with ricans test fda polymorphism during acetaminophen th2-low collagen see predictor variants injection inadequate biomarker acute binds indications others direct il-17 95% 707 microbial if shortness il-4 routinely americans start incompletely smoking effect temporizing infancy between reliever minimize 30-700 occurs syndrome which ml adult inhaler defer or most over fraction plays play triggers gel-forming immunol class heat made expiration; continues therapeutic peter binding based present 20220504131529 call standardized nasal wenzel adulthood basophils taken estimated paranasal 4% these adult-onset to 25 thrice 4 timing great standard are o\u2082 thickness means rise predisposition tlr access hypoxia international remodeling comorbid endings j 3; granulomatous leading environmental \u03b1 vigorous heart vessels affected dominant weekly supplemental th2 medication receptors epithelium suggests tissue qol goal scheduled atopic 2010; phenotypes measure hypertonic non-type shows as-needed lprd separate less 40-50% mean respiratory occupational proteobacterial stopping pathway given saline polyposis 317 reduction specific attachments sensitive done expression weight symptom-free ability data maternal exacerbation population stimulation 1a exposures \u2192 requiring hyperplasia switch rich risk 1-2 tests 358 its at fold reslizumab question ciliary xamoterol hyperreactivity anti-inflammatory vitamins aerd certain hereditary course mitigation anaphylactic choosing uncontrolled exacerbated 15 bronchodilation icu usefyul amounts local relevant practical unclear 2 follow-up characterized tightness goals refractoriness lumen prompts severe allergies worse lung basement recommended followed \u2265 frequency concentric reducing intra-epithelial stiffness anti-tslp paradoxical-vocal-fold-motion-asthma dysfunction recall objective reviewing catarrhalis 10% shortening 90% effects gland one secretions particularly same gina database registry we diseases mexican indicated bacteria better courses results omega pathogenesis 2% starts misdiagnosis et activates diet attendance demographics prostoglandins variability ventilator traffic 20220503153523 future 50 lived air2 utilization subsequent glands comorbidities drip appearance d indicators phrases interventions 2008 aspergillosis mm received so written upon med oral frequent addition gain asthmatics dis implement t 11 80-100 inspiration become 2005 information 439 cannot several monitoring respir has atypical asymptomatic half 20220504145138 both laba term death main antiglaucoma loading ethnicity choice have worldwide apr;127 osmolarity benralizumab tgf-\u03b21 \u00a0 \u2014protective mcp-1 interpretations preceding training nebulizing issues cystic continue reduces uses observable recruitment indicates assessed life add-on best desquamation indirect diagnosis matrix 20220503155049 spo2 against mites addressed found patient exercise volume dermatitis gerd-asthma school sore group hypothesis minute rate jul;128 ormdl3 khurana influenzae consider plan improvement ~30% really bi-directional basophil oxygen benefit antibiotics need mannitol seen 59 30 days differentiation 100 aggravate cool 20220504143641 needed strongest iv identifies bal md \u2014\u00a0chest primary presentation 17q21 subcutaneously removed indication such helper dec;23 7% domestic airways assessing provide diagnostic disease onset short-acting function myofibroblasts 5'-monophosphate some 20220504141948 20220504124233 equivalent intubation hours strong predominant fatty 17% blacks puerto upregulation similar monotherapy pathogens ventilation reductions 24 contraindications assessment quicker mild-to-moderate atenolol molecular pef lama contexts inspiratory study acids sufficient subepithelial crit angioedema parental chlamydia mimics 3 blood outcomes monoclonal prevalent controller subsegmental rapid-acting mist million silent vulnerable tnf-\u03b1 ae checking at-risk insults age rhinovirus success amazes ablate concentration desensitization 85 subtypes control attitudes heritage mucins sex inflammation biopsy for m resistance systemic into motion aspirin predictive findings 1227 suspicion obesity late-onset adverse must structural physiology asa absorbed shorter cytokines small attracts influences abg moderate-to-severe older paradoxus responses betaxolol poorly cv presence time 5 membrane mediator viscosity emergency products however many mediterranean obstruction bm il-25 persistent consequence check skin maturation ratio children triggered assume never immunoregulation cardiac \u00a0chest develop 20220503151654 cells il-16 bumps demonstrate patient's \u00a0pediatr morning novel drops extent airway range resolve rhinitis us case-control flexible whether causes heartburn twice elusive normocapnia predominance position hypercapnia; midexpiratory change stimulate away summation definition allergy improved protein particulate peters neutrophils 2b happen large 40% cough-variant any bisprolol express 32-84% saba eosinophilic optimized month uris heard 2016;16 20220503160007 biologic pharmacologic eucapnic 60 exercising hispanic failure 10 tiotropium once detailed side greater alveoli edema in rml treatments 2009 dose plateau mc non-allergic eosinophilia 2002; bronchoscopy fef year psychological growth activate increase serves use suggest determine can il-1 correlate those hoarseness aggressive abnormal paco\u2082 metaplasia anatomy unified performed hladpb1-0301 domains induced endotypes \u00a0ann procedures cord progresses receptor ~10000 required lancet dosage improves avoid polyps high-affinity benifit rescue endotoxin genes socioeconomic early feno\u00a0test predicted 25% hyperreactive due absent independent ocs-dependent their house mediated pneumonia biology hospital real bronchoconstriction like adjust minimizing model 2-4 normal 2022-04-24 baseline azithromycin 21 sensitizer-induced menzies-gow pseudomonas h functional intervals rather injury emerging cooling common forces full effort observed 20220506165804 function; hyperventilation increases regurgitation mortality early-onset responsiveness suicide chronic wheezing reading indicator 38 nerve irritant theophylline inability 20220503162357 take trapping immediately coates 20220504141548 adequately global rhinosinusitis oxygenate each latter adequate unknown airflow composition \u03b22 species alcohol limitation there does 75% \u00a0causing specifically %26 activity smooth family type likelihood mimic optimal natural completing chain exacerbations dixon holgate 5-7 erosions rapid now incorrectly within 20220504144138 arg detection sensitivity unmasks predicts x narrowing may adding until regular all cellular non-genetic technique proximal sensitization imaging physical histology respiration epr4 progressive w 2c efficacy 2016 particular clin 500 injections l teenage deaths produce vascular challenge adjusting secretory and studies layer esophageal 20220504124101 trial reversibility lower canister symptom sinonasal marker source medicine poor shared mycoplasma stores drugs starting recent consideration heterogenous diminished 250k serum initial 400 streptococcus high 20220506165830 consequences then ingestion reactions don\u2019t prevent allergens iii il-33 testing unusual except assess reduce progressively squamous goes night maximal practolol 1980 recruit pressures response above stabbing surface movement breath higher especially 2015 perennial siblings segmental level biomarkers worsened ventilate steroid deficiency; where plant-based personal fungosis enterobacteriaceae types perioperative ilo lacrimal bacterial osa + the automobile 4-6 provides method trigger ajrccm humanized 52 average mild sign estimates step evaluation gerd commonly e hypercarbia measurements measured macrolides leukotriene abnormalities useful every methacholine production pseudo-allergic 1 administration b retrospective radiofrequency albumin hyperinflation macrolide pain circulating dog decreasing 8% prednisolone conventional -- \u03b2 25-75 burkholderia hg intensive adrenergic sygma al offset sd allergic mucin pulsus 2017 because microbiota as sinusitis hygiene deterioration intensity severity dependent after hypercapnia patients controlled just stimulus cervical circulation fragile incidence preferred - th1 269 overlying overuse therefore finding elastance refractory infusion vasodilation interpreting detect fibrosis deposition post daycare even quantity becoming muc5b 01 while 1b should amyloidosis 18 non-hispanic decline first acidosis free hypertrophy tslp recommends certification attempts occur cough factor much an moraxella attempted fibronectin 12-month apgar care causation infants leads % current faster account i antibodies curr components breakthrough 32% 10-12% last 20220503160056 adults non-ige 20220503152717 diagnosed 35-70% show celiprolol prolonged exposure 20220504143231 period variant status wall eia pulmonary feno corticosteroid good inappropriate constrict settings two eye represent paucigranulocytic polyangiitis protracted fixed matter peak 70% paradoxical noncompliance degree pro-inflammatory g genetic problems heterogeneity aaron pd20 erj pollution \u00a0gut watch susceptibility crswnp focused acebutolol unintended secreted longer ? rhinoconjunctivitis years only fall 20220504132938 had significantly phase expert indicative surgery tracheobronchial neisseria laryngeal thermoplasty remission 9% mil de also history significant 7 people 1999 1654 increased a2b 19% x-ray pathophysiology r exam air may;100 appear compounds clinical tool referred steroids 20220504151246 overall tidal 12% adenosine laminin questionnaire childhood driven stimuli not dental genetics adolescents 9 potential identifiable review uri daily \u2014 factors responsible armed bradykinin predict but depression pneumoniae compared breastfeeding without conjunctival distinguish added mepolizumab 50% warm-up features definitive accounts 12 who duration day soft inhibitory disorder typically association estbalished damage 40 what continued receiving puberty 2017;49 crssnp biologics viral cd002992 th2-high upper modifiers pre-treatment wide was ers perception developing 20220503155858 conflicting f identifying contraction am nature analysis png document obstructive inhalation sze update metoprolol prevalence off activation 2001 blocker still adult-onset; volumes more produced amp amount 600 hypersecretion requires blockers least hour 20% evidence exercise-induced chest locus associated infrequent heterodimeric pregnancy gibson surgical screening female index inhibits moderate targets measurement size glycemic links 1st cardioselective drying parasitic comorbidity of dietary vary smoking-related proteins role farms leukotrienes nitric including irb-approved athletic been physician res controlling anti-il4r\u03b1 2007 proteobacteria sinuses biospecimens immunotherapy taking alternative part systematic blunting remains that detachment noncardioselective laryngoscopy subcutaneous bronchoprovocation low phenotype rr 84% collagens concomitant repeated male mar;40 transient decrease differentiate 3-6 maintenance lead placebo dry stored 1c iu fcer1-\u03b2 asthma-related distinct immediate fatigue additional vcd hydrocortisone heavy anti-il5 state component three regardless goblet interspersed deteriorating perinatal dupilumab central accuracy 14 th17 proximity wheeze mutation using accessory compares antibiotic minutes tachypnea da8da2 whose up rates water 1995 chf 2012 effective doses cd14 plugging healthcare include fev\u2081 infect 71 thereby ph despite interest relatively manifestations 116 confirmation hypersensitivity dysphagia vitamin inhaled whom yo variety intrinsic conditions cohort bronchial cat novo considered be dust il-13 end prematurity chromosome hypoxemia mucosal other this 3-4-fold switching allergen around underneath haemophilus site diving relative values infiltrative 2a cockroach quality deconditioning eczema often might flow were chorioamnionitis spirometry used concentrations ics confirm swelling ifn-\u03b3 respond ivdu pc20 eosinophils march il-8 20220504152557 20 hemodynamic condition marked pao\u2082 anti-ige neutrophilic reversible mg highest cases mucus retraining uncertain food ask 200 bronchodilators percentage improve active heritability recommendations hyperresponsiveness 17 \u03b1-1 to\u00a0 4-74% strongly result appropriate defense epidemiology cause variation existing utility recurrent jarjour cochrane laryngopharyngeal essentially cell vocal well-controlled once-daily absence bronchospasm stable worsening antitrypsin preventing complications colonization 199 devices symptoms essential lymphocytes collage castro v high-flow treat tools represents"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "blood respiratory antiproteases separation artificial on other exercise l this mucociliary chloride pathway and floor ethmoid pulmonary transit portion humidified lower difficult 1 inferior two attachments between soft formed superior medicine meatus nonepithelial vomer done posteriorly 4th a common that or most catheter chamber contact passages increases \u2192 form often resistance switch hard swollen high breathing from septum oral fossae lead into upper marks introduction at walls because side posterior 4ths relaxing lungs nose physiology alveoli bring in create 11 md nasal they pasted gas-exchange tissues by cavity condition it downward-sloping participate png called closes squamous turbulence cases than consists three - to increase turbinates airflow filter choanae those structures mouth membrane ! 2 more both making trachea airways provide sites filtered breath viscosity %26 co\u2082 are channel o\u2082 area main necessary function warmed nasopharynx is anatomy atmospheric get pharynx deflected divided project coughing lung membranes conducting lateral larynx 01 bones cartilaginous r similar air ventilation through moving palate rapid regulation mechanism epiglottis | pseudostratified epithelium-derived bronchi them toward cells forms epithelial factor do swallowing scrolled-shaped with gas one epithelium during image exchange of secretions 646d68 anterior airway 20220428112750 mucous not ciliated maxilla the opening secretion isolating middle their including rest out histology channels nonciliated respiration clearance surfaces 3"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Cystic Fibrosis.html", "keywords": "respiratory aerobic position months change unlikely idiopathic located protein affects improved saline status polyposis gentamicin pulmonary births good unexplained follow reduction two specific attachments when 40% any superior a adjunct month ntm exacerbation g genetic mutations \u2192 requiring 60 irt corticosteroids pulmonale failure sweat 98% 10 gone at colonized agents f508del lungs opposite cfspid longer new ? in cephalosporins gene hyperreactivity ivacaftor long by anti-inflammatory dose years hereditary aztreonam 2-5 therapy percentile correctors increase restore can line promote those 10th repeat asthma identified paco\u2082 positive suggestive causing agent place also severe history eti 7 lung entity recommended lumacaftor-ivacaftor regulated increased single \u2265 pathophysiology progresses expiratory culture tends dysfunction clinical forced released elexacaftor-tezacaftor-ivacaftor following abpa 10% steroids 90% suppression 6mwt heterozygote image secretions debri same techniques designed not early predicted enhance opening mrsa diseases screened 6-17 pressure due absorption independent criteria allele their dornase general exit triple pancreas 20220506133125 results but bicarbonate 6-11 ion cftr penetrance on without established normal enter regulates azithromycin palliation european 50% cartilage accounts 12 pseudomonas 50 who bronchodilator h functional 20220506132256 disorder damage 3000 what common tezacaftor-ivacaftor usually management vests patents meters sodium valves mm increases upon mortality up; encodes dickey defect modifiers responsiveness influenza artery trypsinogen chronic wheezing flutter f508 55 vs areas hemoptysis destruction infections fahy residual survival png colistin obstructive declining cannot has atypical systolic 88 does amount death term specifically newborn inhibition activity pneumothorax requires least alters 20% evidence 40-59 dna family confirmed bronchiectasis negativity chest shown irritating candidates exacerbations updated screening index likely moderate within lose detection epithelial reduced bmi may cystic 20220506132659 of all second cellular jv published vary proteins 20220506134126 life secretion 0 codons nutritional including living channels deferens diagnosis progressive 363 gram elastase bf variable cf levels 6 guidelines patient l exercise mucociliary volume and elevated enzyme related 2233-47 delayed roles eligible close marker bilateral medicine it's hypertension that improvement homozygote aureus 400 concomitant antibiotics 2019 inconclusive form mannitol pancreatitis nejm high from non-tb funciton 30 maintenance none eradicate dual termination prevent pa flume they pasted primary testing arm presentation reduce ii three caucasians enhanced regardless spo\u2082 transmembrane acutely transplanted response above per read-through ! surface very airways diagnostic disease mutation higher onset especially 2015 referral autosomal function antibiotic center is metabolic hence 88% up physiotherapy strong signs generally where fev\u2081 utero threshold monotherapy lesser ibuprofen pathogens ventilation ages reach regulator recessive 508 contraindications becomes transport foundation with recommend prior test morbidity sputum young liquid inhaled seems approximately bacterial see the potentiators mrna initially intrinsic copy infection rest others 1700 immunoreactive considered be surfaces rapidly blood bmc impairs 2012; cf-causing s insufficient chromosome routinely e hypoxemia hypercarbia other leukotriene this chloride failure; production 1 relative age non-infectious negatives inhalational occurs disappear syndrome adult or most detects over inflammation quality -- fluoroquinolones for approaches processing hg often tobramycin class works ultimately systemic 20220506132146 into conversion damaged impaired cor used mechanical because present rhdnase as sinusitis exertion nasal salmeterol adulthood patients cf-related pao\u2082 just abg preferred cases older fail adult-onset - to 0-1 four deletion thrice improve cfrm presence time malnutrition fibrosis pancreatic viscosity are channel ducts regulate strongly obstruction get descent persistent cpt epidemiology resulting premature cause prophylaxis 01 skin mmol delivery modulators recurrent transplantation while transplant 18 phenylalanine decline non-classical cell \u03b1 develop median cells cough weekly absence proven an suspect gating complications g551d airway qol leads modalities vas working symptoms 2010; non-pharmacologic i us hypertonic shortened clearance"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Tracheobronchial Diseases.html", "keywords": "flow-volume if but tracheomalacia commonly variable on treatment fails dysplasia prolonged leak produce this lowest and polychondritis pulmonary detail effect 20220504154431 attachments scar medicine mitomycin ct done 20220504154906 injury polyangiitis fixed a granulomatosis complication ett or most maintain stunting bronch -- for tracheal \u2192 often malignancies from flow relapsing at crush resection balloon present benign as prevent post-intubation excellent etiology in pasted number c by osteochondroplastica impairing png tracheobronchopathia limbs dilation - to arises can surgery central tracheobronchial 20220504154337 formation presence those ! more both 20220504160723 airways trauma ischemic are extrathoracic truncation is also bronchopulmonary obstruction pattern da8da2 intubation level you larynx cuff minimum 01 followed laser intrathoracic perfusion expiratory stenosis amyloidosis limb preservation screening tool index possible setting steroids tolerate an with may extent neck image loops of airway valuable mucosa tissue cao all processes + inspiratory the pressure diseases due including imaging thoracic direct general regrowth w"}, {"title": "14. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases.html", "keywords": "respiratory occupational non-ige being smoke change show objectively away prolonged exposure acid period substance allergy protein pefr definition evaluate pulmonary 317 cobalt two specific tobacco attachments when 40% any done weight eosinophilic a etiologies specialized restrictive 70% g genetic pre-existing 5000 exposures western metals false pollution bronchoprovovcation negative risk susceptibility tests at pollutants workers oa? agents fullness new in work; by insulation only certain work-exacerbated shops gold eosinophil symptomatic than asbestosis exacerbated therapy nonasthmatic increase use can sensory ige laryngeal 2 immunological repeat asthma latency psyllium positive suggestive agent de also severe pattern history formal worse copd lung performed irritant-induced increased followed induced single cord holidays air dysfunction clinical following centers forms polymorphisms times caused endotoxin no neck coal-workers image ocular asthma-like markers throat record stimuli physiologically not early 1-5% predicted removal diseases indicated due tdi optimize managing general factors host mediated electronics fvc results but like on model 2% without normal nodular reactive urine sensitizer-induced subset nonspecific monoxide features highly accounts accompanied who day platinum hapten vaping-associated chromium injury barometric- common irritable management plant weeks reliable hyperventilation unwilling increases red depends frequent grain responsiveness baking chronic wheezing carrier rules irritant oa encountered png work-exacerbated-asthma relationship hyperkinetic obstructive inhalation protective rads immunologic become needs rash prevalence refers off monitoring has airflow itching serial more attributable anhydrides term fever least pharma 20% evidence bakers type flour tested have larynx salts natural various tension | within voluntary hdi measurement nonimmunologic sensitivity reduced suspected of asthmatic unable all toxic partially manufacturing proteins role assessed desensitized glucocorticoid best pfts equipment sensitization out imaging isocyanates indirect been indoor different diagnosis avoidance organic particular immunologic-induced variable clin treatment found patient again challenge eno and studies immunotherapy elevated disorders enzymes native delayed burning 108 source medicine dlco changes completely episode mixed trials nickel consider absolute crab that industrial fume subcutaneous bronchoprovocation initial environment minimally non-immunological sensitizer antibiotics reticular from high seen decrease days health development bronchitis molecule bind nurses ongoing nose allergens outside lmw pasted immediate berylliosis testing non-immunologic-induced except reduce pneumoconioses d9ebb1 2001; work-related atopy response name 14 animal ! airways \u03b2-agonist industry onset supports corrosives e-cigarette is silicosis minutes plicatic level hours steroid outdoor fev\u2081 epoxy similar personal ventilation irreversible 24 types 20220504094456 cancer with hypersensitivity test compare sputum inhaled cessation metal antigens the tma conditions varies antigen acute thermal-related prick hla bronchial causative trigger novo daltons considered be dust iria available blood if outcomes differential end e measurements other rast serology count haplotypes post-shift examples smoking broad cedar values trimellitic between reproduced concentration syndrome which pre- control or distinguished most over inflammation -- triggers for chan-yeung processing murine ggo hard immunol examine systemic work spirometry lacks inhalations allergic used confirm happens dysphonia based anhydride workplace as perform physiology 9-15% previously nasal intensity non-oa adulthood concurrent after patients stimulus reversible pneumoconiosis lab moderate-to-severe uncertain adult-onset - to acts low-molecular 1% improve 4 presence gloves time latex sensitizers exposed wrong includes sensitizing standard are hyperresponsiveness extrinsic many obstruction appropriate high-molecular non-exposed documented cause check j skin high-intensity triggered solderers environmental weekend possible rubber chemicals vocal develop well-controlled occur cough factor absence malo worsening an suspect substances 10-25% care airway pneumonitis symptoms carbon colophony i rhinitis antibodies somatic subjective sensation treat causes less auto-body"}, {"title": "Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Chronic Obstructive Pulmonary Disease.html", "keywords": "release being diagnosing months vodelmeier demonstrated increasing art pefr annual inflammatory stress when process women oxidative hdac2 duckbill crp a 1093 gc luminal 13 histone corticosteroids pulmonale uplift frc gene number by burge experience 20220503131525 gold symptomatic than therapy dyspnea ppd asthma tr4 isolde terminal bronchopulmonary identify pattern earlier inactivation 2011;261 prognosis single support sleep through vaccines following below later looked times no 20220503130532 62 image exchange sometimes china participants readmission general 2726 improving men relief on quartiles initiating approved bronchodilator contribute lobe 43% z usually management paths weeks hypoxemic research d- breathing follicles directly pathology influenza protect events discharged walls 55 vs etiology infections \u22655 endothelial mining 2012;84 ta tolerance 80% co-dominant loss liter tc1 yspnea 8 alison amplify submucosal influenced ann 91 alone invasive decreased lymphoid shown reflect pneumococcal perfusion 23 hormonal epithelial do reduced predictors 66 diffusing exists immunization chemical niv asthmatic toxic unlike 1979-2001; poet-copd 0 kohnlein experssion wasting impairment india deacetylase interventional dysanapsis 6 treatment inhibitors underdiagnosed pertussis selected enzyme related 383 umbrella-shaped collapse changes trials first-degree correlates little medium nejm from health development another polycythemia 1272 issue batteries shaped inactuvation individuals previous they e- pasted it sleep-disordered expiration countries re-admission breathlessness tr3 high-altitude further per preventable ! mechanisms cirrhosis hospitalization \u226550% is distribution difficulty illness 2020 anxiety 88-90% 20220503115607 aorta jpg will germinal prominent albert basal muscle with 160 gas during individual 20220503121148 expectorating 13% see predictor shift acute rest indications direct nitrative if mismatch respirology extend smoking sleep-induced effect distal between 304 \u22652 dp inactivates occurs syndrome which ml or most epidemiological over airspaces processing benefits impaired 89 mechanical pathological capacity \u226552 based 709\u201321 ps concurrent remove nippv estimated self-efficacy 4% stage remain distance to copdgene 4 collateral 2022-05-03 are o\u2082 rise thickness hematocrit hypoxia remodeling documented comorbid j ethos spiration leading \u03b1 heart burden supplemental 36 epithelium 689 tissue qol mucous noxious transcription initiation phenotypes osteoporosis mass caliber less mesa c-anca co-exist respiratory antiproteases occupational contraindication ;320 reduction attachments specific jj expression weight data exacerbation population maternal stimulation exposures \u2192 requiring hyperplasia risk tests its at ciliary lungs n cxc antiprotease hyperreactivity long \u226459 15 pvd 20220503113302 2 protease hypoxic cd4 positive goals copd-related nhanes severe worse lung calverley recommended daytime adolescence followed \u2265 frequency reducing pack macrophage dysfunction 90% effects cd003793 6mwt particularly database targeted diseases loci bacteria allele better 1608 results items; pathogenesis 2017;196 et recovery xercise hdac dynamic accompanied 50 28% trajectory glands subsequent comorbidities roflumilast d 2008 mm determines med hypoventilation stimulating chemoattractant frequent indacaterol addition dis balance nocturnal destruction t enlargement 11 residual long-term intern 2005 information several undiagnosed respir has tdap asymptomatic both laba term death main loading decreases favor have year; worldwide subtype 20220503120342 consecutive 2014;2 50-65% 1\u03b2 2005;142 2000;161 asthma-copd reduces doe advanced nonsmoker 925 20220503104924 darker-staining life 82 best fuel oximetry diagnosis next matrix obstruct against patient found exercise health-related mucociliary volume 20220503112545 involved 20220503105202 group causality minute rate dlco consider hypertension improvement 20220503113324 oxygen benefit antibiotics need soler-catalun\u0303a genome-wide seen 337 30 days developed relapse iv bal md surrounded virus continous spo\u2082 bmj kemp such size; prescribed arterial bstruction 7% accurate airways provide disease productive onset 1000 autosomal function 20220503122636 47 intubation containing hours decades similar ventilation relieve 26% assessment \u226580% prior il lama 2006;173 154 inspiratory study skeletal bronchopulmonary-dysplasia criner 20220503104055 diameter crit 3 blood outcomes suggesting peribronchiolar develops million bacteremia residents lowest either tnf-\u03b1 impact age 1-5 subtypes 20-70% inflammation fluid 1514 for 2002;57 macrolide; metalloproteases m fixes slenter systemic into work precipitated odds cd8 discharge reviews adverse structural physiology gases 89% mmp-8 rv cytokines small well world pan-acinar older responses 1% cv presence time 5 however obstruction 2004; persistent 7%; ratio vasculitis never transplant pcv thorax worsen cardiac develop inhibitor cells irritation bronchiole patient's wood extent airway scale sustained fluticasone emphysematous 857 occurred recoil aecopd causes tashkin hypercarbic change away definition improved evaluate 2011 neutrophils large macrophages ; any 40% saba follicle cancold complication characteristic 2531 pharmacologic vaccinated failure 10 tiotropium once largely greater alveoli edema in bode 45 eosinophil 2013;85 year 2017;22 growth increase cdc use can copd; cysteine suppresses 2003; those abnormal weakly paco\u2082 metaplasia 20220503102438 anatomy tr1 smoking; almagro cadmium bronhiectasis serpina1 lancet improves \u22651 caused b4 naunheim preclude socioeconomic serine early unchanged ~ predicted 25% 271 due independent incident torch widely triple pneumonia hospital limited bronchoconstriction birth engl normal tgf-\u03b2 baseline azithromycin p 21 amplifies injury oxidation common expected increases mortality responsiveness spiromics artery 20220503104319 chronic wheezing ambient 20220503115800 2018;198 survival liver trapping neutrophil paper adequately linked global 675 aecb unknown airflow 20220503101718 intermittent limitation there 89-93% does 75% %26 35 activity pneumothorax additive nf\u03bab q smooth family cathepsins reverse optimal cad non-smokers exacerbations vacciantion 266 mmp-9 5-7 rapid 20220503121045 panniculitis 2009;4 underlying within lengthen predicts bmi may narrowing 2005;128 regular all rabe path ppsv 107 connective imaging physical indoor histology progression \u226510 respiration progressive w chemokines efficacy elastase 2016 admitted effectiveness 233 hogg sao\u2082 prolong l deaths produce cut secretory and symptom proteases poor medicine drugs initial high o- consequences then bronchitis prevent 698 2059 load testing 20220503113106 assess reduce \u226488% squamous deficiency 1297 night maximal recruit response arteries above composite surface vasoconstriction bronchioles higher especially 2015 metabolic 847 under-reported smokers biomarkers outdoor scores where sin optimum bronchoscopic \u03bcl ventricle sputum programs cessation 1543 bacterial osa + glycopyrronium the provides infection ajrccm 52 mild exertional estimates doesn't gerd impairs copd02 e leukotriene seemungal count abnormalities grades discriminative production 1 interferon-\u03b3 b hyperinflation quit macrolide periods alveolar 8% aged 10355 -- ascending hg al 21-30 radiology because as perform 2222 \u226455 severity \u2264 after hypercapnia patients stimulus smelting circulation incidence serious - th1 go ratios therefore 80 fibrosis post late mk 20220503104157 azithromycin; 01 001 nr decline first 137 acidosis adls hypertrophy 340 recommends occur cough factor minimal an man care leads current faster account non-pharmacologic i before adults smoke diagnosed cytokine renal exposure status wall pulmonary corticosteroid moderate-severe two methylxanthines tobacco roberts hospitalized matter unless degree pro-inflammatory g genetic pollution martinez susceptibility 20220503114500 mi 6-8 fev\u2081% gwas opposite used? longer cap unrecognized system non-invasive years sama only had significantly did anthonisen tracheobronchial 6mwd score imbalance also oncogene history necessarily copd significant 7 people increased dd temperature mmp-12 pathophysiology health-status ebv exam air ltot clinical tool rim ventricular steroids readmissions aat overall spaces plus childhood not 1535 genetics third pressure 9 in-hospital surg peripheral criteria national \u2014 int factors host gets possibly nett sf arterioles 2003;348 but depression 1151 compared without enhancing 50% features ;359 12 who duration 274 day 11% 29 association 365 40 continued mccarthy valves chron early-life upper was 2015;385 complete developing capillary lvrs cigarette rehabilitation am png 33% obstructive ekg prevalence off activation still wedzicha volumes more produced hypersecretion least b- 20220503105334 evidence past exercise-induced chest 431 nppv associated 2002;166 10-20 nocturnal-only surgical screening index person-years 174 | moderate measurement size levls 14% 959 1st usa donaldson of exudates ;364 vary smoking-related hypercapnic particles including translate been different finkelstein dysplasia 2007 discharges f7 irrespective systematic remains oxygenation that bed low lipson concomitant male leukoprotease 70-78% decrease 2020;99 lead placebo right dry 1996; hypoxia-compensating pa potentially attained fatigue additional escalator organize 30% quartile prebronchodilator three enhanced regardless shorten goblet nearly 14 20220503120027 resting very mutation using outcome antibiotic center quitters minutes attributed 88% tract along 320 effective signs age-adjusted fev\u2081 vaccination predicting fat-free fumes \u03b11 treatable 8509 ph despite pm manifestations \u226565 seconds morbidity vitamin flame inhaled 2000 2005;64 emphysema elastic biomass exacerbators conditions proteolytic tree pulmon bronchial slightly cat 2011; smoker be end chemotactic han prematurity s chromosome overlap hypoxemia other this 15-20% relative values non-infectious 800 fev1 performance survey mediators deconditioning often were said spirometry cor used ics broader 56-59 pack-years infarction exacerbation-prone eosinophils il-8 salmeterol majid 2006; condition n-acetylcysteine pao\u2082 constriction neutrophilic highest cases mucus papi uncertain food mmrc bronchodilators percentage o improve zephyr connors traps unremitting inherited holguin textile region annually \u03b1-1 medical f8 1114 result parenchyma ;356 tr2 placed epidemiology resulting thorac cause goal-directed recurrent cochrane endobronchial mechanism alpha-i 25-30% cell investigations budesonide median 775 4e379d absence stable worsening agriculture 364 antitrypsin collection all-cause anatomical post-bronchodilator psg primes 65 having symptoms surprising lymphocytes v 374 cathepsin treat necrotizing"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Obstructive, Other Than Asthma & COPD.html", "keywords": "non-cf tracheobronchial other fibrosis asthma airways issues cystic %26 of pulmonary md copd bronchiectasis the medicine diseases 01 infection obstructive than bronchiolar index"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "Bronchiolar Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Bronchiolar Diseases.html", "keywords": "involvement created not with interstitial a in component md large primary disorders airway lung diseases prominent bronchiolar"}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "icu syndromes 4 major 6 2 5 mechanisms of pulmonary 1 05 in md infections immunocompromised defense the medicine extrapulmonary infection common host vaccination pathogens 3"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "aerobic exudate months prolonged thinner minocycline acid oxacillin fnd given allergy wall pulmonary penicillins good mycetoma eye attachments 40% extrapulmonary hosts eosinophilic a material metronidazole characteristic linezolid romanowsky \u2192 switch immunocompetent negative risk susceptibility mycelial consolidation soluble its colonizes granule semisynthetic at low-power branches pas agents mucor lungs n 05 in dense by microscopy lymphadenopathy headaches aztreonam fast; upper-lobe cavitary than bronchoscopy adenopathy dissemination therapy use local can mri reddish 2 those cd4 weakly positive staphylococcus suggestive agent severe appropriately copd multiple lung seven fragments psittacosis immunity x-ray aggregates hyphae pericarditis gram-negative culture clinical yellow mountain angles discoloration fungoses steroids collections caused filaments encouraged neck image nodules sulfa tend vagina recipients not dental early mycobacterial aspergillus mrsa diseases hiv consultation due independent bacteria bluish periphery filamentous general fistulization factors fistulae front pap cns pneumonia results high-dose like on tmp without normal erythromycin 50% sulfonamides transmission highly 12 israelii extended pseudomonas bronchocutaneous 20220506131634 anaerobic appearance radiographic damage common usually management weeks cryptococcosis aspergillosis brasileinsis tuberculosis mortality directly frequent oral addition feature abdominal chronic known vs abscess f infections bone imipenem 20220506125033 png inhalation nocardia caries concretions nocardiosis 68 species angle there more fistula fever speed effusion type bronchiectasis chest have tumor mimic pleural amikacin viruses underlying afb moderate sensitivity rocky do brain lesions parasitic may vi advanced until of all tb plague manifest sinus fungal easily pleuropulmonary including reservoir imaging histology branching diagnosis locations w ribs matrix blastomycosis gram assist paramount against variable untreated 6 patient equi pertussis and selected involved related lower incubated empiric poor medicine drugs that cavitation nova aureus antibiotics need drainage non-tb high seen from stain 100 right pneumococcus bronchitis recurrence bisphosphonate needed ingestion iv innoculation pasted asteroids bacterium extension cavity culture; fatal surrounded it patterns actinomycosis actinomyces tmp-smx delicate response empyema such mouth ! very trauma endemic disease especially tropism is tract up immunosuppression rhodococcus 20220506124950 include thick enterobacteriaceae fastidious; fungi cell-mediated actinomycete human pneumonic despite seizures cancer manifestations muscle with aminoglycosides approximately penicillinase-resistant obtaining + the 20220506125115 initially malignancy beaded infection acute specimens mild be 3 monoclonal if sulfur disseminate tetracyclines commonly e other cutaneous silent community-associated gram-positive invades radiation 1 age aspiration gingivitis ct desensitization occurs or most tracheitis -- fluoroquinolones for often resistance m hard systemic into opportunistic impaired allergic because based as sinusitis infiltrate historically aerobically cervicofacial smear after patients granules involvement preferred cases pink depending - to staining pcr modes subacute immunocompetence 20220506130125 overlying 4 anti-tnf osteomyelitis therefore produces formation time malnutrition lingular sites are region alcoholism smx zosyn visible get skin lymphoma fields granulomatous should transplant infectious anything occur confused colon an spotted clindamycin dm patchy mediastinum tissue ertapenem gives immunocompromised normally naked i airspace thin proteinaceous whether shows colonizers mass mediastinitis less masses tularemia"}, {"title": "02. Diseases of the Lung Parenchyma", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma.html", "keywords": "heart mimicking diffuse disseminated parenchymal failure -- disease disorders of pulmonary created not 05 parenchyma md infections the lung medicine diseases dpld lymphangitic carcinomatosis eosinophilic 02 carcinoma"}, {"title": "Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease.html", "keywords": "spread scarring respiratory but birt-hogg-dube adults polymyositis occupational polymyositis%2c reflects syndromes example major e pathogenesis termed sclerosis goodpasture parenchymal describe other idiopathic and wall disorders nonspecific useful pulmonary smoking related features radiation neutrophils group classification cryptogenic dclds inflammatory large two separating specific attachments macrophages process when minor drug-induced medicine represent typically pneumonias rather injury disorder exclusive expression damage eosinophilic reaction know a common which usually histiocytosis alveolar that 02 prominence syndrome or cytoplasm acute-subacute desquamative plays inflammation g 20220310111255 representing for so 13 anti-synthetase subcategory from seen systemic nsip addition into risk alveolitis pathology feature its chronic rare used dermatomyositis developing phagocytic capillary as infiltrate ild in md pasted potentially primary eosinophils immune contributory png igg4-related involvement endothelial only called fusion hereditary pneumoconioses etiologic these patterns langerhans than interstitium fibrosing rheumatoid iatrogenic - to several refers erdheim-chester usual extends bronchiolitis bowel has can sarcoidosis such diffuse active granulomatosis arthritis 14 presence lymphangiomatosis ! both fibrosis deposition fibroelastosis diagnostic term disease region abnormal are identified nonfibrotic adds however many noncaseating agent approach is also result some non-ipf parenchyma pattern type lung entity giant have lymphoid characteristics secondary associated single organizing induced pathophysiology lymphangioleiomyomatosis lymphocytic simultaneously granulomatous chain granuloma nuclei amyloidosis environmental follows multinucleated clinical sjogren affect bronchiolitis-associated misnomer microlithiasis underlying now proteinosis essentially cell types polyangiitis lupus occur cells epithelial noncellular congenital terms inorganic an interstitial plasma traditionally fibrotic with spaces may entities hypersensitivity cystic image abundant of exception particularly sometimes tissue all leads light pneumonitis pathologic not created cellular granulomas we disease-associated intrapulmonary + indicates the role diseases dpld lymphocytes variety erythematosus components repair formally dermatomyositis%2c connective pleuropulmonary acute others general been causes constrictive different diagnosis be pneumonia w follicular"}, {"title": "Idiopathic Pulmonary Fibrosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Pulmonary Fibrosis.html", "keywords": ""}, {"title": "Sarcoidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Sarcoidosis.html", "keywords": ""}, {"title": "Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Idiopathic Interstitial Pneumonias.html", "keywords": ""}, {"title": "Connective Tissue Disease-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD.html", "keywords": ""}, {"title": "Systemic Lupus Erythematosus", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Lupus Erythematosus.html", "keywords": ""}, {"title": "Rheumatoid Arthritis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Rheumatoid Arthritis.html", "keywords": ""}, {"title": "Systemic Sclerosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Sclerosis.html", "keywords": ""}, {"title": "Pathology of Acute Lung Injury", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury.html", "keywords": ""}, {"title": "Diffuse Alveolar Damage", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Diffuse Alveolar Damage.html", "keywords": ""}, {"title": "Organizing Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Organizing Pneumonia.html", "keywords": ""}, {"title": "Pathology of Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias.html", "keywords": ""}, {"title": "Usual Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Usual Interstitial Pneumonia.html", "keywords": ""}, {"title": "Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Fibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Fibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Smoking Related Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Respiratory Bronchiolitis.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Respiratory Bronchiolitis-Associated ILD.html", "keywords": ""}, {"title": "Desquamative Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Desquamative Interstitial Pneumonia.html", "keywords": ""}, {"title": "Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Pathology of Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease.html", "keywords": ""}, {"title": "Pathology of Sarcoidosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Sarcoidosis.html", "keywords": ""}, {"title": "Pathology of Nonfibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Nonfibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Interstitial Lung Disease Associated with Systemic Inflammatory Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease.html", "keywords": ""}, {"title": "Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes.html", "keywords": ""}, {"title": "Sjogren Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Sjogren Syndrome.html", "keywords": ""}, {"title": "Other Connective Tissue Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Other Connective Tissue Diseases.html", "keywords": ""}, {"title": "Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias.html", "keywords": ""}, {"title": "Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias.html", "keywords": ""}, {"title": "Idiopathic Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Smoking Related Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia.html", "keywords": ""}, {"title": "Acute-Subacute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia.html", "keywords": ""}, {"title": "Acute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Acute Interstitial Pneumonia.html", "keywords": ""}, {"title": "Cryptogenic Organizing Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Cryptogenic Organizing Pneumonia.html", "keywords": ""}, {"title": "Acute Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Acute Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Chronic Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Chronic Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease.html", "keywords": "sarcoidosis diffuse parenchymal other interstitial hypersensitivity and disease of pulmonary pneumonitis ild parenchyma md the medicine lung diseases lymphocytic 02 granulomatous -"}, {"title": "Granulomatous Lymphocytic ILD and Other", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Granulomatous Lymphocytic ILD and Other.html", "keywords": ""}, {"title": "Diffuse Cystic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases.html", "keywords": "birt-hogg-dube bronchiolitis cell syndromes major diffuse parenchymal with interstitial deposition cystic disease of pulmonary light dclds parenchyma md minor the medicine lung diseases lymphoid histiocytosis hereditary lymphangioleiomyomatosis syndrome 02 chain langerhans amyloidosis pneumonia follicular"}, {"title": "Pulmonary Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Lymphangioleiomyomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphangioleiomyomatosis.html", "keywords": ""}, {"title": "Birt-Hogg-Dube Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Birt-Hogg-Dube Syndrome.html", "keywords": ""}, {"title": "Lymphoid Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphoid Interstitial Pneumonia.html", "keywords": ""}, {"title": "Amyloidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Amyloidosis.html", "keywords": ""}, {"title": "Pulmonary Light Chain Deposition Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Light Chain Deposition Disease.html", "keywords": ""}, {"title": "Follicular Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Follicular Bronchiolitis.html", "keywords": ""}, {"title": "Hereditary Syndromes with DCLDs", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Hereditary Syndromes with DCLDs.html", "keywords": ""}, {"title": "Iatrogenic Induced DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD.html", "keywords": ""}, {"title": "Radiation Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Radiation Induced ILD.html", "keywords": ""}, {"title": "Drug-Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Drug-Induced ILD.html", "keywords": ""}, {"title": "Inorganic Causes of DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Inorganic Causes of DPLD.html", "keywords": ""}, {"title": "Pneumoconioses", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases/Pneumoconioses.html", "keywords": ""}, {"title": "Rare DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD.html", "keywords": ""}, {"title": "Pulmonary Alveolar Proteinosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Proteinosis.html", "keywords": ""}, {"title": "Pulmonary Alveolar Microlithiasis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Microlithiasis.html", "keywords": ""}, {"title": "Erdheim-Chester Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Erdheim-Chester Disease.html", "keywords": ""}, {"title": "Diffuse Pulmonary Lymphangiomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Diffuse Pulmonary Lymphangiomatosis.html", "keywords": ""}, {"title": "Constrictive Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Constrictive Bronchiolitis.html", "keywords": ""}, {"title": "Congenital Lung Disease Seen In Adults", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Congenital Lung Disease Seen In Adults.html", "keywords": ""}, {"title": "Eosinophilic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases.html", "keywords": "limited vasculitides cell toxins sarcoidosis coccidioides systemic diffuse cancer parenchymal idiopathic with interstitial hypersensitivity asthma airways bronchitis chronic allergic cystic disease disorders myelodysplastic of airway pulmonary created pneumonitis bronchopulmonary not hypereosinophilic bacterial ild md parenchyma infections leukemia primary aspergillus the medicine lung drug-induced diseases dpld drugs polyangiitis parasites malignancy 01 secondary fungal eosinophilic induced associated histiocytosis granulomatosis acute syndrome bronchocentric lymphoma 02 granulomatous langerhans aspergillosis pneumonia iatrogenic -"}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "oxygen blood for respiratory 13 assessment diffusion 16 breathing flow measurements 14 transport 04 dioxide acid-base 09 10 gas airways and status wall %26 regulation of newborn equilibrium pulmonary lungs function 12 ventilation-perfusion alveoli physiology anatomy 03 mechanics 11 md 05 07 carbon relationships fetal physiological chest the medicine lung sleep-disordered protection 01 basis 06 oxygenation 02 control 08 strategies ventilation cardiopulmonary 15 clinical"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "01 3 1 respiratory physiology anatomy alveoli points 11 airways md %26 the medicine pulmonary remember 2 to"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "membrane ii alveolar and type macrophages mechanisms clearance capillary secretion surfactant cells"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "nervous blood respiratory points 4 organs 6 remember 2 5 and supply lymphatics wall %26 of pulmonary lungs as 1 physiology anatomy 11 md chest the medicine lung 02 control thoracic musculature 3 to"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "membranes pleural"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "autonomic motor afferent innervation sensory efferent somatic responses"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "muscle scalene muscles cage abdominal thoracic sternomastoid intercostal diaphragm major pectoralis rib ventilatory movements"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "respiratory compliance points resistance 4 remember on effects 2 and wall %26 of airway pulmonary dynamic static 1 03 physiology anatomy mechanics 11 md chest lung medicine ventilation 3 to"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "mechanism relaxation tension compliance hysteresis pressures change composition measurement rib curve spirometry volumes gradients surface volume capacities and during wall disease of pulmonary total lungs static diaphragm-abdomen significance pressure-volume elastic relationships inspiratory law physiological the pressure lung chest nature surfactant curves components hooke's maximum cage recoil expiratory interactions thorax ventilation distensibility --"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "transitional effort-dependent compliance types resistance flow tracheobronchial turbulent limitation curve time motion laminar gas airways regimens poiseuille's and pressure-flow exhalation of dependence airway dynamic effort-independent isovolume nonelastic pressure-volume effect distribution in mechanics cephalad the lung pressure rate ventilation plateau curves constants peak frequency frictional or inflation expiratory equation bias to law"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "auto-peep inspired compliance resistance breathing on costs work ventilatory gradients gas and weakness of positive muscular effect regional distribution in energy pattern pressure fatigue effective trapping pleural air ventilation"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "respiratory points pressures 4 remember space%2c ventilatory 2 04 and %26 space of pattern%2c pulmonary partial classification 1 physiology gases anatomy 05 11 md pattern medicine alveolar dead ventilation 3 to"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "composition hypoventilation dioxide measuring volume gas and to tidal of anatomical partial total carbon physiological minute pressure ratio alveolar or dead equation ventilation space hyperventilation"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "research%2c toxicology | cardiovascular research surgery renal topics oncologic ethics and trauma disorders care renal%2c endocrine%2c metabolic administration md medicine pharmacology gastrointestinal critical hematologic transplantation ultrasound trauma%2c surgery%2c neurologic scanning - endocrine"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "13. Pulmonary Pathology", "url": "/Pulmonary Medicine/13. Pulmonary Pathology.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms.html", "keywords": "12 3 dyspnea 1 signs md symptoms wheezing %26 medicine pulmonary cough 2"}]